CR20150246A - Composición inmunogénica contra la aeromonas hydrophila - Google Patents

Composición inmunogénica contra la aeromonas hydrophila

Info

Publication number
CR20150246A
CR20150246A CR20150246A CR20150246A CR20150246A CR 20150246 A CR20150246 A CR 20150246A CR 20150246 A CR20150246 A CR 20150246A CR 20150246 A CR20150246 A CR 20150246A CR 20150246 A CR20150246 A CR 20150246A
Authority
CR
Costa Rica
Prior art keywords
immunogenic composition
hydrophila
airports
composition against
composition
Prior art date
Application number
CR20150246A
Other languages
English (en)
Inventor
Vo Thanh Tung
Tran Duy Phuong
Le Thi Kim Phuong
Nguyen Truong Phuc
Anja Nygaard
Liv Blom Hungerholdt
Leif Are Klevan
Original Assignee
Pharmaq As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaq As filed Critical Pharmaq As
Publication of CR20150246A publication Critical patent/CR20150246A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36Adaptation or attenuation of cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Es un objetivo de la presente invención proporcionar una composición, por ejemplo, en forma de una composición inmunogénica o una vacuna para la protección de los peces contra la infección de Aeromonas hydrophila.
CR20150246A 2012-10-24 2015-05-11 Composición inmunogénica contra la aeromonas hydrophila CR20150246A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
VN201203153 2012-10-24
DKPA201370328 2013-06-18
PCT/EP2013/072319 WO2014064217A1 (en) 2012-10-24 2013-10-24 Immunogenic composition against aeromonas hydrophila

Publications (1)

Publication Number Publication Date
CR20150246A true CR20150246A (es) 2015-08-14

Family

ID=49619879

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20150246A CR20150246A (es) 2012-10-24 2015-05-11 Composición inmunogénica contra la aeromonas hydrophila

Country Status (7)

Country Link
EP (1) EP2912198B1 (es)
CN (2) CN105121625B (es)
CR (1) CR20150246A (es)
ES (1) ES2655679T3 (es)
MX (1) MX368601B (es)
NO (1) NO2912198T3 (es)
WO (1) WO2014064217A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105695372B (zh) * 2016-04-18 2018-05-08 华中农业大学 一种高致病性嗜水气单胞菌及应用
CN105886429B (zh) * 2016-04-18 2019-04-02 华中农业大学 一种无抗生素标记的嗜水气单胞菌减毒菌及应用
CN106906141B (zh) * 2017-02-21 2021-05-04 河南师范大学 一种嗜水气单胞菌活菌疫苗菌株的筛选方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY158116A (en) * 2006-07-06 2016-08-30 Intervet Int Bv Combination vaccine against streptococcus
CN101642567A (zh) * 2009-01-14 2010-02-10 张秀军 一种嗜水气单胞菌灭活疫苗及其制备
US7988977B2 (en) * 2009-02-27 2011-08-02 The United States Of America As Represented By The Secretary Of Agriculture Modified live Aeromonas hydrophila vaccine for aquatic animals
US8637049B2 (en) * 2011-04-06 2014-01-28 The United States Of America, As Represented By The Secretary Of Agriculture Attenuated live vaccines for aquatic animals

Also Published As

Publication number Publication date
NO2912198T3 (es) 2018-04-21
MX368601B (es) 2019-10-09
EP2912198A1 (en) 2015-09-02
CN105121625A (zh) 2015-12-02
MX2015005112A (es) 2015-10-29
CN105121625B (zh) 2020-10-16
WO2014064217A1 (en) 2014-05-01
ES2655679T3 (es) 2018-02-21
CN111840531A (zh) 2020-10-30
EP2912198B1 (en) 2017-11-22

Similar Documents

Publication Publication Date Title
HK1243949A1 (zh) 包含***素的口腔護理組合物
CL2018000515A1 (es) Virus de la enfermedad de newcastle y usos de los mismos (divisional sol. 2532-2015)
CL2017003151A1 (es) Formulaciones para vacunas contra la neoplasia y métodos para preparar las mismas
UY34772A (es) ?una formulación de fármaco de liberación retardada?.
CR20150326A (es) Inhibidores de autotaxina
GT201500005A (es) Composiciones de vacuna para la prevencion contra la infeccion por el virus del dengue
BR112013028281A2 (pt) compostos e composições para inibição de nampt
BR112015008272A2 (pt) cápsula para preparação de bebidas
BR112016012862A2 (pt) formulações para vacinas para neoplasia
MY168959A (en) Vaccine compositions for the prevention of dengue virus infection
BR112016002855A2 (pt) cápsula de segurança para recipientes
CL2015001562A1 (es) Método para obtener una vacuna de mycoplasma.
DK3513806T3 (da) Immunogen sammensætning
CL2016002536A1 (es) Composiciones y métodos para productos de fibra de yeso resistentes al agua
BR112017004197A2 (pt) composições de vacina contra doenças do vírus da dengue
BR112016008458A2 (pt) embalagem de cápsulas de uso único, máquina para embalar e método para embalar
BR112017003891A2 (pt) métodos e composições para induzir imunidade protetora contra infecção por filovírus
CL2016001152A1 (es) Vacuna para peces
UY34679A (es) ?PROCEDIMIENTO PARA OBTENER UNA COMPOSICIÓN DE IgG MEDIANTE TRATAMIENTO TÉRMICO?
BR112014005788A2 (pt) variante de antitripsina alfa-1, método de preparação da mesma e aplicação da mesma
DK3193917T3 (da) Vaccinesammensætninger, der omfatter tryptophan-2,3-dioxygenase eller fragmenter deraf
CR20150246A (es) Composición inmunogénica contra la aeromonas hydrophila
CL2012002654A1 (es) Compuesto de propilmetilfenol o una composicion que lo comprende para tratar septicemia rickettsial salmonidea (srs) y/o enfermedades causadas por la piscirickettsia salmonis.
UY34286A (es) Diagnóstico de vacuna mejorado
BR112015013106A2 (pt) uso de extrato de feno-grego para melhorar a libido feminina